BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30905821)

  • 1. GloPID-R report on Chikungunya, O'nyong-nyong and Mayaro virus, part I: Biological diagnostics.
    Pezzi L; Reusken CB; Weaver SC; Drexler JF; Busch M; LaBeaud AD; Diamond MS; Vasilakis N; Drebot MA; Siqueira AM; Ribeiro GS; Kohl A; Lecuit M; Ng LFP; Gallian P; de Lamballerie X;
    Antiviral Res; 2019 Jun; 166():66-81. PubMed ID: 30905821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 2: Epidemiological distribution of o'nyong-nyong virus.
    Pezzi L; LaBeaud AD; Reusken CB; Drexler JF; Vasilakis N; Diallo M; Simon F; Jaenisch T; Gallian P; Sall A; Failloux AB; Weaver SC; de Lamballerie X;
    Antiviral Res; 2019 Dec; 172():104611. PubMed ID: 31545982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 3: Epidemiological distribution of Mayaro virus.
    Pezzi L; Rodriguez-Morales AJ; Reusken CB; Ribeiro GS; LaBeaud AD; Lourenço-de-Oliveira R; Brasil P; Lecuit M; Failloux AB; Gallian P; Jaenisch T; Simon F; Siqueira AM; Rosa-Freitas MG; Vega Rua A; Weaver SC; Drexler JF; Vasilakis N; de Lamballerie X ;
    Antiviral Res; 2019 Dec; 172():104610. PubMed ID: 31545981
    [No Abstract]   [Full Text] [Related]  

  • 4. GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 5: Entomological aspects.
    Pezzi L; Diallo M; Rosa-Freitas MG; Vega-Rua A; Ng LFP; Boyer S; Drexler JF; Vasilakis N; Lourenco-de-Oliveira R; Weaver SC; Kohl A; de Lamballerie X; Failloux AB;
    Antiviral Res; 2020 Feb; 174():104670. PubMed ID: 31812638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model-based assessment of Chikungunya and O'nyong-nyong virus circulation in Mali in a serological cross-reactivity context.
    Hozé N; Diarra I; Sangaré AK; Pastorino B; Pezzi L; Kouriba B; Sagara I; Dabo A; Djimdé A; Thera MA; Doumbo OK; de Lamballerie X; Cauchemez S
    Nat Commun; 2021 Nov; 12(1):6735. PubMed ID: 34795213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High rates of o'nyong nyong and Chikungunya virus transmission in coastal Kenya.
    LaBeaud AD; Banda T; Brichard J; Muchiri EM; Mungai PL; Mutuku FM; Borland E; Gildengorin G; Pfeil S; Teng CY; Long K; Heise M; Powers AM; Kitron U; King CH
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003436. PubMed ID: 25658762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O'nyong-nyong fever: a neglected mosquito-borne viral disease.
    Rezza G; Chen R; Weaver SC
    Pathog Glob Health; 2017 Sep; 111(6):271-275. PubMed ID: 28829253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of Chikungunya and O'nyong-Nyong Virus Specificity for Infection of
    Cottis S; Blisnick AA; Failloux AB; Vernick KD
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplex detection of antibodies to Chikungunya, O'nyong-nyong, Zika, Dengue, West Nile and Usutu viruses in diverse non-human primate species from Cameroon and the Democratic Republic of Congo.
    Raulino R; Thaurignac G; Butel C; Villabona-Arenas CJ; Foe T; Loul S; Ndimbo-Kumugo SP; Mbala-Kingebeni P; Makiala-Mandanda S; Ahuka-Mundeke S; Kerkhof K; Delaporte E; Ariën KK; Foulongne V; Mpoudi Ngole E; Peeters M; Ayouba A
    PLoS Negl Trop Dis; 2021 Jan; 15(1):e0009028. PubMed ID: 33476338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No Evidence of O'nyong-nyong Viremia among Children with Febrile Illness in Kenya (2015-2018).
    Shah MM; Ndenga BA; Mutuku FM; Okuta V; Ronga CO; Chebii PK; Maina P; Jembe Z; Sahoo MK; Huang C; Weber J; Pinsky BA; LaBeaud AD
    Am J Trop Med Hyg; 2021 Feb; 104(4):1435-1437. PubMed ID: 33617476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a Real-Time Reverse Transcription Polymerase Chain Reaction for O'nyong-nyong Virus and Evaluation with Clinical and Mosquito Specimens from Kenya.
    Waggoner J; Heath CJ; Ndenga B; Mutuku F; Sahoo MK; Mohamed-Hadley A; Vulule J; Mukoko D; Desiree LaBeaud A; Pinsky BA
    Am J Trop Med Hyg; 2017 Jul; 97(1):121-124. PubMed ID: 28719301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenicity and virulence of O'nyong-nyong virus: A less studied
    Tong Jia Ming S; Tan Yi Jun K; Carissimo G
    Virulence; 2024 Dec; 15(1):2355201. PubMed ID: 38797948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FHL1 promotes chikungunya and o'nyong-nyong virus infection and pathogenesis with implications for alphavirus vaccine design.
    Ng WH; Liu X; Ling ZL; Santos CNO; Magalhães LS; Kueh AJ; Herold MJ; Taylor A; Freitas JR; Koit S; Wang S; Lloyd AR; Teixeira MM; Merits A; Almeida RP; King NJC; Mahalingam S
    Nat Commun; 2023 Oct; 14(1):6605. PubMed ID: 37884534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal [18F]FB-IL-2 PET Imaging to Assess the Immunopathogenicity of O'nyong-nyong Virus Infection.
    Chan YH; Teo TH; Torres-Ruesta A; Hartimath SV; Chee RS; Khanapur S; Yong FF; Ramasamy B; Cheng P; Rajarethinam R; Robins EG; Goggi JL; Lum FM; Carissimo G; Rénia L; Ng LFP
    Front Immunol; 2020; 11():894. PubMed ID: 32477364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and evaluation of an external quality control and internal quality control containing real-time RT-PCR assay for the detection of o'nyong-nyong virus.
    Wang HB; Du T; Lin JH; Chen XB; Tu CN
    Biologicals; 2023 Nov; 84():101717. PubMed ID: 37801802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological Responses in Patients Infected with Mayaro Virus and Evaluation of Cross-Protective Responses against Chikungunya Virus.
    Bopp NE; Jencks KJ; Siles C; Guevara C; Vilcarromero S; Fernández D; Halsey ES; Ampuero JS; Aguilar PV
    Am J Trop Med Hyg; 2021 Nov; 106(2):607-609. PubMed ID: 34844213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chikungunya Virus Exposure Partially Cross-Protects against Mayaro Virus Infection in Mice.
    Fumagalli MJ; de Souza WM; de Castro-Jorge LA; de Carvalho RVH; Castro ÍA; de Almeida LGN; Consonni SR; Zamboni DS; Figueiredo LTM
    J Virol; 2021 Nov; 95(23):e0112221. PubMed ID: 34549980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced Molecular Surveillance of Chikungunya Virus.
    Fischer C; de Lamballerie X; Drexler JF
    mSphere; 2019 Jul; 4(4):. PubMed ID: 31270168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robustness of Serologic Investigations for Chikungunya and Mayaro Viruses following Coemergence.
    Fischer C; Bozza F; Merino Merino XJ; Pedroso C; de Oliveira Filho EF; Moreira-Soto A; Schwalb A; de Lamballerie X; Netto EM; Bozza PT; Sarno M; Brites C; Gotuzzo E; Talledo M; Drexler JF
    mSphere; 2020 Feb; 5(1):. PubMed ID: 32024703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of Alphaviruses (
    Abdoullah B; Durand GA; Basco LK; El Bara A; Bollahi MA; Bosio L; Geulen M; Briolant S; Boukhary AOMS
    Viruses; 2023 Jul; 15(7):. PubMed ID: 37515274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.